{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:40:16Z","timestamp":1780551616602,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.2353\/ajpath.2006.050646","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T15:40:20Z","timestamp":1174059620000},"page":"1309-1320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Generalized Lysosome-Associated Membrane Protein-2 Defect Explains Multisystem Clinical Involvement and Allows Leukocyte Diagnostic Screening in Danon Disease"],"prefix":"10.1016","volume":"168","author":[{"given":"Marina","family":"Fanin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Nascimbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Fulizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Melacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Angelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2006.050646_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.050646_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1212\/WNL.58.12.1773","article-title":"Clinicopathological features of genetically confirmed Danon disease","volume":"58","author":"Sugie","year":"2002","journal-title":"Neurology"},{"key":"10.2353\/ajpath.2006.050646_bib3","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"key":"10.2353\/ajpath.2006.050646_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/bbrc.1995.2528","article-title":"An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner","volume":"215","author":"Konecki","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.2353\/ajpath.2006.050646_bib5","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1242\/jcs.02447","article-title":"The apoptosis\/autophagy paradox: autophagic vacuolization before apoptotic death","volume":"118","author":"Gonzalez-Polo","year":"2005","journal-title":"J Cell Sci"},{"key":"10.2353\/ajpath.2006.050646_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal membrane proteins","volume":"13","author":"Eskelinen","year":"2003","journal-title":"Trends Cell Biol"},{"key":"10.2353\/ajpath.2006.050646_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.101.1.85","article-title":"Identification of two lysosomal membrane glycoproteins","volume":"101","author":"Chen","year":"1985","journal-title":"J Cell Biol"},{"key":"10.2353\/ajpath.2006.050646_bib8","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1091\/mbc.e02-02-0114","article-title":"Role of LAMP2 in lysosome biogenesis and autophagy","volume":"13","author":"Eskelinen","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.2353\/ajpath.2006.050646_bib9","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/35022595","article-title":"Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice","volume":"406","author":"Tanaka","year":"2000","journal-title":"Nature"},{"key":"10.2353\/ajpath.2006.050646_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4615-2401-4_7","article-title":"Biogenesis of the lysosomal membrane","volume":"22","author":"Fukuda","year":"1994","journal-title":"Subcell Biochem"},{"key":"10.2353\/ajpath.2006.050646_bib11","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1242\/jcs.113.24.4441","article-title":"Unique properties of LAMP2 compared to other LAMP2 isoforms","volume":"113","author":"Cuervo","year":"2000","journal-title":"J Cell Sci"},{"key":"10.2353\/ajpath.2006.050646_bib12","series-title":"Electrocardiography in Clinical Practice: Adult and Pediatric","first-page":"37","article-title":"Left ventricular hypertrophy","author":"Chou","year":"1996"},{"key":"10.2353\/ajpath.2006.050646_bib13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0002-9440(10)63551-1","article-title":"Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression","volume":"163","author":"Fanin","year":"2003","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2006.050646_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/humu.20058","article-title":"Molecular diagnosis of LGMD2A: gene mutation analysis or protein testing?","volume":"24","author":"Fanin","year":"2004","journal-title":"Hum Mut"},{"key":"10.2353\/ajpath.2006.050646_bib15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2004.09.041","article-title":"Cytoplasmic nonsense-mediated mRNA decay for a nonsense (W262X) transcript of the gene responsible for hereditary tyrosinemia, furmarylacetoacetate hydrolase","volume":"324","author":"Dreumont","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.2353\/ajpath.2006.050646_bib16","first-page":"1229","article-title":"Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation","volume":"51","author":"Allen","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.2353\/ajpath.2006.050646_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s004390050909","article-title":"A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR","volume":"104","author":"Kubota","year":"1999","journal-title":"Hum Genet"},{"key":"10.2353\/ajpath.2006.050646_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.10235","article-title":"Germline mosaicism of a novel mutation in lysosome-associated membrane protein-2 deficiency (Danon disease)","volume":"52","author":"Takahashi","year":"2002","journal-title":"Ann Neurol"},{"key":"10.2353\/ajpath.2006.050646_bib19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0960-8966(02)00179-7","article-title":"Danon's disease (X-linked vacuolar cardiomyopathy and myopathy): a case with novel LAMP-2 gene mutation","volume":"12","author":"Lacoste-Collin","year":"2002","journal-title":"Neuromuscul Disord"},{"key":"10.2353\/ajpath.2006.050646_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-2003-43262","article-title":"Identification of a novel LAMP2 mutation responsible for X-chromosomal dominant Danon disease","volume":"34","author":"Horvath","year":"2003","journal-title":"Neuropediatrics"},{"key":"10.2353\/ajpath.2006.050646_bib21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0960-8966(03)00105-6","article-title":"Characterization of Danon disease in a male patient and his affected mother","volume":"13","author":"Sugie","year":"2003","journal-title":"Neuromuscul Disord"},{"key":"10.2353\/ajpath.2006.050646_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/hrt.2003.029504","article-title":"Danon's disease as a cause of hypertrophic cardiomyopathy: a systematic survey","volume":"90","author":"Charron","year":"2004","journal-title":"Heart"},{"key":"10.2353\/ajpath.2006.050646_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad","year":"2005","journal-title":"N Engl J Med"},{"key":"10.2353\/ajpath.2006.050646_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nmd.2004.12.007","article-title":"Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)","volume":"15","author":"Lobrinus","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.2353\/ajpath.2006.050646_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1471-4914(00)01868-2","article-title":"Disease model: LAMP-2 enlightens Danon disease","volume":"7","author":"Saftig","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.2353\/ajpath.2006.050646_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nmd.2005.02.008","article-title":"Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene","volume":"15","author":"Musumeci","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.2353\/ajpath.2006.050646_bib27","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.105.546481","article-title":"Danon disease as an underrecognized cause of hypertrophic cardiomyopathy in children","volume":"112","author":"Yang","year":"2005","journal-title":"Circulation"},{"key":"10.2353\/ajpath.2006.050646_bib28","first-page":"1200","article-title":"Localization of dystrophin and beta-spectrin in vacuolar myopathies","volume":"143","author":"De Bleecker","year":"1993","journal-title":"Am J Pathol"},{"key":"10.2353\/ajpath.2006.050646_bib29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1403","article-title":"Nonsense-mediated decay approaches the clinic","volume":"36","author":"Holbrook","year":"2004","journal-title":"Nat Genet"},{"key":"10.2353\/ajpath.2006.050646_bib30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/hmg\/8.10.1893","article-title":"Nonsense-mediated mRNA decay in health and disease","volume":"8","author":"Frischmeyer","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.2353\/ajpath.2006.050646_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tig.2005.01.007","article-title":"A new function for nonsense-mediated mRNA-decay factors","volume":"21","author":"Wilkinson","year":"2005","journal-title":"Trends Genet"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010627071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010627071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T14:16:49Z","timestamp":1757600209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010627071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0002944010627071"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2006.050646","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized Lysosome-Associated Membrane Protein-2 Defect Explains Multisystem Clinical Involvement and Allows Leukocyte Diagnostic Screening in Danon Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2006.050646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}